| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-8703(90)90026-T |
| P698 | PubMed publication ID | 2389702 |
| P50 | author | William B. Kannel | Q15439387 |
| David R. Gagnon | Q42132642 | ||
| Ralph B. D'Agostino Sr. | Q59209521 | ||
| Peter Wilson | Q89854449 | ||
| Albert J. Belanger | Q124757546 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 672-676 | |
| P577 | publication date | 1990-09-01 | |
| P1433 | published in | American Heart Journal | Q2227156 |
| P1476 | title | Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience | |
| P478 | volume | 120 |
| Q36268407 | 4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome |
| Q46020499 | A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with Type 1 (insulin-dependent) diabetes mellitus |
| Q40948163 | A new diagnostic classification for hypertension. |
| Q43042437 | Acute insulin resistance stimulates and insulin sensitization attenuates vascular smooth muscle cell migration and proliferation |
| Q40287232 | Adaptive Upregulation of Clumping Factor A (ClfA) by Staphylococcus aureus in the Obese, Type 2 Diabetic Host Mediates Increased Virulence |
| Q24814535 | Age and kidney function are the primary correlates of fasting plasma total homocysteine levels in non-diabetic and diabetic adults. Results from the 1999-2002 National Health and Nutrition Examination Survey |
| Q28564881 | Age-related changes in coagulation, fibrinolysis, and platelet aggregation in male WBN/Kob rats |
| Q73076613 | Application of HELP in nonarteritic anterior ischemic optic neuropathy: a prospective, randomized, controlled study |
| Q46956035 | Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus |
| Q44434968 | Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus |
| Q53018745 | Atherosclerotic disease in very old age: Preliminary results from the Berlin aging study (base). |
| Q47764147 | Biologic markers as predictors of cardiovascular disease |
| Q33649443 | Cardiovascular consequences of polycystic ovary syndrome |
| Q28192271 | Cardiovascular disease: much more aggressive in patients with type 2 diabetes |
| Q51570754 | Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: a population-based survey among Asians in Singapore. |
| Q37284133 | Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review |
| Q73315387 | Cerebrovascular reactivity and reserve capacity in type II diabetes mellitus |
| Q45217221 | Changes in aorta alpha1-adrenoceptor number and affinity during one year of streptozotocin-induced diabetes in rats |
| Q37220941 | Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation |
| Q28165202 | Chronic expression of platelet adhesion proteins is associated with severe ischemic heart disease in type 2 diabetic patients: Chronic platelet activation in diabetic heart patients |
| Q71751796 | Circulating endothelin-1 levels in type 2 diabetic patients with ischaemic heart disease |
| Q74348457 | Clinical impact and health economic consequences of posttransplant type 2 diabetes mellitus |
| Q36808834 | Comorbidities Associated with Obstructive Sleep Apnea: a Retrospective Study |
| Q73305730 | Comparison of risk factors of macrovascular complications. Peripheral vascular disease, cerebral vascular disease, and coronary heart disease in Japanese type 2 diabetes mellitus patients |
| Q34506784 | Current medical therapies for patients with peripheral arterial disease: a critical review |
| Q73447660 | Dermatan sulphate, heparin cofactor II, and F1+2 peptide in non-insulin-dependent diabetes mellitus |
| Q28165854 | Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial |
| Q41457652 | Determinants of coronary vascular disease in patients with type II diabetes mellitus and their therapeutic implications. |
| Q33762031 | Diabetes and ischemic heart disease |
| Q34451762 | Diabetes mellitus and coronary heart disease |
| Q28743200 | Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values |
| Q42506566 | Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein |
| Q33722865 | Drug selection and the management of corticosteroid-related diabetes mellitus |
| Q35911582 | Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study |
| Q44423210 | Effect of Metformin and Sulfonylurea on C-Reactive Protein Level in Well-Controlled Type 2 Diabetics with Metabolic Syndrome |
| Q34774079 | Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study). |
| Q48344853 | Effects of acute blood pressure elevation on biochemical-metabolic parameters in individuals with hypertensive crisis. |
| Q36839933 | Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation |
| Q51553762 | Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. |
| Q28195408 | Emerging drugs in peripheral arterial disease |
| Q37808750 | Erectile dysfunction and testosterone screening with prostate specific antigen screening at age 40: are these three gender specific determinants additive for overall men's heath and do they improve traditional non-gender specific determinants to les |
| Q37730636 | Evaluation of serum fibrinogen, plasminogen, α2-anti-plasmin, and plasminogen activator inhibitor levels (PAI) and their correlation with presence of retinopathy in patients with type 1 DM. |
| Q54204660 | Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease. |
| Q34349703 | Evidence of left ventricular dysfunction in asymptomatic elderly patients with non-insulin-dependent diabetes mellitus. |
| Q36415833 | Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome |
| Q55372718 | Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography. |
| Q33739135 | Fibrinogen and women's health |
| Q33612628 | Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study |
| Q50907848 | Fibrinogen is an independent marker for thoracic aortic atherosclerosis. |
| Q40744822 | Fibrinogen: an important risk factor for atherothrombotic diseases |
| Q35538771 | Fibrinogen: biochemistry, epidemiology and determinants |
| Q40725303 | Fibrinogen: its emerging role as a cardiovascular risk factor |
| Q41197312 | Gene expression changes in human islets exposed to type 1 diabetic serum. |
| Q35184558 | Hepatotoxicity of the thiazolidinediones |
| Q43578630 | Hyperfibrinogenemia and metabolic syndrome in type 2 diabetes: a population-based study |
| Q40781707 | Hyperglycemia-induced production of acute phase reactants in adipose tissue |
| Q73843507 | Hypertension in special populations |
| Q34180071 | Impaired modulation of circadian rhythms in patients with diabetes mellitus: a risk factor for cardiac thrombotic events? |
| Q46736692 | Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study |
| Q44268388 | Incidence and risk factors for cardiovascular disease in African Americans with diabetes: the Atherosclerosis Risk in Communities (ARIC) study |
| Q74062478 | Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2 |
| Q35932352 | Insulin resistance in patients with polycystic ovary syndrome |
| Q44739963 | Insulin resistance in polycystic ovary syndrome |
| Q49288215 | International validation of the CLAU-S quality-of-life questionnaire for use in patients with intermittent claudication |
| Q37618707 | Is intermittent vasculogenic claudication still a nonsurgical disease? |
| Q74298764 | Issues and challenges with antithrombotic therapy in diabetic patients with acute coronary syndromes |
| Q35937178 | Long-term clinical benefits of a platelet glycoprotein IIb/IIIa receptor blocker, abciximab (ReoPro), in high-risk diabetic patients undergoing percutaneous coronary intervention |
| Q37154802 | Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone |
| Q36907339 | Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis |
| Q40948177 | Metabolic abnormalities in cardiac ischemia. |
| Q37621075 | Modeling metabolic homeostasis and nutrient sensing in Drosophila: implications for aging and metabolic diseases |
| Q40923118 | New approaches to the prevention of atherosclerosis |
| Q34274596 | Non-insulin-dependent (type II) diabetes mellitus |
| Q41526058 | Nonlipoprotein risk factors for coronary heart disease: Evaluation and management |
| Q36320564 | Pathobiology and cell interactions of platelets in diabetes |
| Q35091909 | Pharmacological treatment of patients with peripheral arterial disease |
| Q72024131 | Plasma macromolecular protein complex: Interaction with fibrin and fibrinolysis |
| Q35174193 | Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective |
| Q22241923 | Prediction of Coronary Heart Disease Using Risk Factor Categories |
| Q35582120 | Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome |
| Q34557152 | Proteomic analysis in type 2 diabetes patients before and after a very low calorie diet reveals potential disease state and intervention specific biomarkers |
| Q34856964 | Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitus |
| Q37157478 | Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS) |
| Q24812441 | Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients |
| Q43857796 | Relationship of abdominal fat with metabolic disorders in diabetes mellitus patients |
| Q41386031 | Response: the prevalence of peripheral arterial disease in korean patients with type 2 diabetes mellitus attending a university hospital (diabetes metab j 2011;35:543-50). |
| Q46103338 | Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors |
| Q40802331 | Secondary causes of hyperlipidemia. |
| Q30234726 | Sex differences in cardiovascular disease - Impact on care and outcomes |
| Q35129591 | Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study. |
| Q41864421 | The Diagnostic Value of Tc-99m MIBI Gated Myocardial Perfusion SPECT in Detection of Silent Myocardial Ischemia in Asymptomatic Patients with Type 2 Diabetes Mellitus |
| Q64260454 | The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study |
| Q46466743 | The influence of type 2 diabetes on fibrin structure and function |
| Q35564091 | The prevalence of peripheral arterial disease in korean patients with type 2 diabetes mellitus attending a university hospital |
| Q37314571 | The prognostic value of blood glucose level on admission in non-diabetic patients with acute myocardial infarction. |
| Q40811005 | The role of haematological factors in diabetic peripheral arterial disease: the Edinburgh artery study |
| Q72616618 | Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients |
| Q48124567 | Tissue factor activities of streptozotocin induced diabetic rat tissues and the effect of peanut consumption |
| Q35896355 | Triglyceride predicts cardiovascular mortality and its relationship with glycaemia and obesity in Chinese type 2 diabetic patients. |
| Q36957436 | Value of exercise tolerance testing in evaluation of diabetic patients presented with atypical chest discomfort |
Search more.